Novanta outlays $1.45bn for Riverpoint Medical buyout

Mergers & Acquisitions
Novanta has agreed to acquire Riverpoint Medical for up to $1.45 billion to strengthen its position in the medical consumables market and enter the minimally invasive surgery segment. The deal includes $1.2 billion upfront in...

Novanta outlays $1.45bn for Riverpoint Medical buyout

Mergers & Acquisitions
Novanta has agreed to acquire Riverpoint Medical for up to $1.45 billion to strengthen its position in the medical consumables market and enter the...

GT Medical completes oversubscribed $100M Series E

Funding
GT Medical Technologies has closed an oversubscribed $100 million Series E financing to support the growth of its GammaTile radiation therapy device, designed for...

CeQur closes $100M Series E to support mealtime insulin patch

Funding
CeQur has raised $100 million in Series E financing to support the expansion of its Simplicity wearable mealtime insulin patch, a device designed to...

Xenix Medical announces FDA clearance and full commercial launch of the Lux System

Regulatory Approvals
Xenix Medical announced FDA 510(k) clearance and full commercial launch for its Lux Expandable Lumbar Interbody Fusion System. Lux is the result of strong market...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart

Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform. The company completed an acute in vivo...

Reflow Medical has positive data for coronary drug-eluting stent

Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system. San Clemente, California-based Reflow designed its...

Innovation

Regulatory Approvals

Novanta outlays $1.45bn for Riverpoint Medical buyout

Novanta has agreed to acquire Riverpoint Medical for up to $1.45 billion to strengthen its position in the medical consumables market and enter the...

GT Medical completes oversubscribed $100M Series E

GT Medical Technologies has closed an oversubscribed $100 million Series E financing to support the growth of its GammaTile radiation therapy device, designed for...

CeQur closes $100M Series E to support mealtime insulin patch

CeQur has raised $100 million in Series E financing to support the expansion of its Simplicity wearable mealtime insulin patch, a device designed to...

Xenix Medical announces FDA clearance and full commercial launch of the Lux System

Xenix Medical announced FDA 510(k) clearance and full commercial launch for its Lux Expandable Lumbar Interbody Fusion System. Lux is the result of strong market...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1153Regulatory Approvals1022Innovation655Clinical Trials525Mergers & Acquisitions510GS Funding Tracker52